The aethera trial: An ongoing phase 3 study of brentuximab vedotin in the treatment of patients at high risk of residual Hodgkin lymphoma following autologous stem cell transplant Meeting Abstract
| Authors: | Moskowitz, C.; Nadamanee, A.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M.; Chen, A.; Stiff, P.; Gianni, A.; Carella, A.; Osmanov, D.; Sweetenham, J.; Sureda, A.; Huebner, D.; Hunder, N.; Yang, Y.; Walewski, J. |
| Abstract Title: | The aethera trial: An ongoing phase 3 study of brentuximab vedotin in the treatment of patients at high risk of residual Hodgkin lymphoma following autologous stem cell transplant |
| Meeting Title: | 2014 BMT Tandem Meetings |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 20 |
| Issue: | 2 Suppl. 1 |
| Meeting Dates: | 2014 Feb 26-Mar 2 |
| Meeting Location: | Grapevine, TX |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2014-02-01 |
| Start Page: | S115 |
| End Page: | S116 |
| Language: | English |
| ACCESSION: | WOS:000331155400153 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2013.12.168 |
| Notes: | Poster Session I; Meeting Abstract: 148 -- BMT Tandem Meetings -- FEB 26-MAR 02, 2014 -- Grapevine, TX -- 1 -- Source: Wos |
